Modulation of Plasma Sphingosine-1-phosphate Levels via Dietary Salt Intervention in Chinese Adults: An Intervention Trial
暂无分享,去创建一个
J. Mu | Yu Yan | Q. Ma | Ke-ke Wang | Yue-yuan Liao | C. Chu | Wen-ling Zheng | Jiawen Hu | Yue Yuan | Yang Wang | Yanbo Xue | Yueyuan Liao | Keke Wang | PH Chen | Qiong Ma
[1] Hong Liu,et al. Inverse Correlation Between Plasma Sphingosine-1-Phosphate and Ceramide Concentrations in Septic Patients and Their Utility in Predicting Mortality , 2019, Shock.
[2] J. Mu,et al. An expert recommendation on salt intake and blood pressure management in Chinese patients with hypertension: A statement of the Chinese Medical Association Hypertension Professional Committee , 2019, Journal of clinical hypertension.
[3] M. Ballantyne,et al. Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse , 2019, European journal of pharmacology.
[4] I. Kanazawa,et al. Visceral fat accumulation is associated with increased plasma sphingosine-1-phosphate levels in type 2 diabetes mellitus. , 2018, Diabetes research and clinical practice.
[5] G. Lip,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.
[6] S. Mousa,et al. High Plasma Sphingosine 1-phosphate Levels Predict Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study , 2018, Journal of bone metabolism.
[7] D. Lyon,et al. Paradoxical Association of Postoperative Plasma Sphingosine-1-Phosphate with Breast Cancer Aggressiveness and Chemotherapy , 2017, Mediators of inflammation.
[8] A. Planas,et al. Sphingosine-1-phosphate signalling—a key player in the pathogenesis of Angiotensin II-induced hypertension , 2017, Cardiovascular research.
[9] Rachel K. Johnson,et al. Recommended Dietary Pattern to Achieve Adherence to the American Heart Association/American College of Cardiology (AHA/ACC) Guidelines: A Scientific Statement From the American Heart Association , 2016, Circulation.
[10] N. Cook,et al. Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. , 2016, Hypertension.
[11] E. Gao,et al. Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction. , 2016, American Journal of Physiology. Heart and Circulatory Physiology.
[12] E. Schwedhelm,et al. Decreased serum concentrations of sphingosine-1-phosphate in sepsis , 2015, Critical Care.
[13] T. Hla,et al. Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure , 2015, Nature Medicine.
[14] J. Jeppesen,et al. Network-based analysis of the sphingolipid metabolism in hypertension , 2015, Front. Genet..
[15] J. Garcia,et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. , 2014, American journal of respiratory and critical care medicine.
[16] Y. Alsancak,et al. The Relationship between Pre-Infarction Angina and Serum Sphingosine-1-Phosphate Levels. , 2014, Acta Cardiologica Sinica.
[17] S. Yusuf,et al. Association of urinary sodium and potassium excretion with blood pressure. , 2014, The New England journal of medicine.
[18] D. Hemmings,et al. Review: novel insights into the regulation of vascular tone by sphingosine 1-phosphate. , 2014, Placenta.
[19] A. Lisowska,et al. Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction. , 2013, Prostaglandins & other lipid mediators.
[20] S. Milstien,et al. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond , 2013, Nature Reviews Drug Discovery.
[21] S. Ünlü,et al. The relationship between preinfarction angina and serum sphingosine 1 phosphate levels , 2013 .
[22] R. Fryer,et al. The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat , 2012, PloS one.
[23] S. Peters,et al. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase , 2012, British journal of pharmacology.
[24] J. Cyster,et al. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. , 2012, Annual review of immunology.
[25] T. Hla,et al. Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. , 2011, Chemical reviews.
[26] M. Tölle,et al. Pharmacological relevance and potential of sphingosine 1‐phosphate in the vascular system , 2011, British journal of pharmacology.
[27] T. Jørgensen,et al. Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension , 2011, BMC Genetics.
[28] Pin-Lan Li,et al. A novel lipid natriuretic factor in the renal medulla: sphingosine-1-phosphate. , 2011, American journal of physiology. Renal physiology.
[29] J. Kroetsch,et al. Sphingosine-1-Phosphate–Dependent Activation of p38 MAPK Maintains Elevated Peripheral Resistance in Heart Failure Through Increased Myogenic Vasoconstriction , 2010, Circulation research.
[30] T. Michel,et al. Sphingosine-1-phosphate and modulation of vascular tone. , 2009, Cardiovascular research.
[31] E. Ritz,et al. Salt and its effect on blood pressure and target organ damage: new pieces in an old puzzle. , 2009, Journal of nephrology.
[32] Y. Okamoto,et al. Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system. , 2008, Biochimica et biophysica acta.
[33] M. Gaasenbeek,et al. Candidate Genes That Determine Response to Salt in the Stroke-Prone Spontaneously Hypertensive Rat: Congenic Analysis , 2007, Hypertension.
[34] J. Omens,et al. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. , 2007, American journal of physiology. Heart and circulatory physiology.
[35] R. Proia,et al. Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes , 2004, Journal of Pharmacology and Experimental Therapeutics.
[36] T. Hla,et al. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. , 2002, Biochimica et biophysica acta.
[37] D. Mazurais,et al. Cell Type-specific Localization of Human Cardiac S1P Receptors , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[38] M. Weinberger,et al. Salt sensitivity of blood pressure in humans. , 1996, Hypertension.
[39] Thomas Kahan,et al. [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.
[40] Xian-cheng Jiang,et al. Sphingolipid metabolism and atherosclerosis. , 2013, Handbook of experimental pharmacology.
[41] L. Mazzolai,et al. Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. , 2010, European heart journal.